Literature DB >> 6085359

Nitrendipine: hemodynamic effects in conscious normotensive and spontaneously hypertensive rats.

B L Pegram, I Kobrin, S Sesoko, E D Frohlich.   

Abstract

The effects of immediate (1 h) and prolonged (3 weeks) treatment with nitrendipine on systemic and regional hemodynamics were investigated in Wistar-Kyoto (WKY) and spontaneously hypertensive (SHR) rats. Mean arterial pressure (MAP) was significantly (p less than 0.05) decreased in both WKY (125 +/- 2 versus 108 +/- 3 mm Hg) and SHR (189 +/- 5 versus 141 +/- 10 mm Hg) 1 h following oral nitrendipine administration (10 mg/kg). This was associated with a significant (p less than 0.05) decrease in total peripheral resistance index (TPRI) (0.48 +/- 0.03 versus 0.38 +/- 0.02 units/kg, WKY; 0.69 +/- 0.04 versus 0.56 +/- 0.05 units/kg SHR) but no change in cardiac index (CI). A significant (p less than 0.05) increase in heart rate (HR) (374 +/- 14 versus 407 +/- 11 beats/min) was observed only in WKY. Vascular resistances were reduced significantly (p less than 0.05) in heart and kidney in both SHR and WKY as well as the brain and splanchnic organs of the WKY. Resistance increased significantly in SHR skin. The MAP reduction with prolonged treatment (196 +/- 3 versus 181 +/- 4 and 150 +/- 5 mm Hg) was also associated with a reduced TPRI (0.73 +/- 0.03 versus 0.64 +/- 0.07 and 0.50 +/- 0.03 units/kg) in SHR treated for 3 weeks with nitrendipine (10 and 20 mg/kg/day, respectively). No changes in systemic hemodynamics were observed in similarly treated WKY. Skeletal muscle and splanchnic vascular resistances were reduced (p less than 0.05) in nitrendipine-treated WKY (20 mg/kg/day).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6085359

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  4 in total

1.  Cardiovascular effects of two new calcium antagonists, PY 108-068 and PN 200-110, in conscious spontaneously hypertensive rats.

Authors:  C Barrès; C Cerutti; B Morin; J Sassard
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

Review 2.  'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications.

Authors:  D D Freedman; D D Waters
Journal:  Drugs       Date:  1987-11       Impact factor: 9.546

Review 3.  Nitrendipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension.

Authors:  K L Goa; E M Sorkin
Journal:  Drugs       Date:  1987-02       Impact factor: 9.546

4.  Comparison of antihypertensive effect and pharmacokinetics of conventional and extended release felodipine tablets in patients with arterial hypertension.

Authors:  T Hedner; D Elmfeldt; C Dahlöf; E Sjögren
Journal:  Drugs       Date:  1987       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.